Romania's labour market is undergoing a structural transformation as the country shifts from consumption-driven growth to a more technology-focused economy, with artificial intelligence and automation reshaping employment patterns.
Romania's headline inflation rose to 9.6% in January 2026, a figure slightly exceeding market expectations due to a significant surge in utility costs.
Romania's economy delivered a mild upside surprise in the third quarter, with flash estimates pointing to 1.6% annual growth, above expectations. However, the economy still contracted by 0.2% versus the previous quarter. After nine months of 2025, the economy is 0.8% above the same period of 2024, according to a report by ING Bank Romania.
Romanian inflation eased slightly to 9.8% in October from 9.9% in September, with declining food prices providing some relief while services inflation remained elevated. The National Bank of Romania is expected to maintain current rates until mid-2026.
Romania's GDP is projected to expand modestly from 0.9% in 2024 to 1.2% in 2025, though significant downside risks, including geopolitical tensions, cloud this outlook, finds new research by ING Romania economists.
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.